Clinical Trials Browser

Phase NA × Arthralgia × Docosahexaenoic Acids × Clear all

NCT02831582 2023-02-27

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Phase NA Completed

Breast Neoplasms, Arthralgia